Kyprolis® (carfilzomib) in combination with either lenalidomide and dexamethasone or dexamethasone alone is indicated for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.
*Significant improvement in median progression-free survival with both KRd and Kd combination treatments.1,2
Please read the SmPC for full comprehensive safety information
- Stewart AK et al. N Engl J Med 2015;372:142–152.
- Dimopoulos MA et al. Lancet Oncol 2016;17:27–38.